Next Article in Journal
Simple and Efficient Synthesis of 2,7-Difunctionalized-1,8-Naphthyridines
Previous Article in Journal
A New iso-Amyl Benzothiazolyl Sulfoxide as an Extractant for Palladium and the Crystal Structure of its Palladium (II) Complex
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 10
Issue 8
10.3390/10080922
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Investigation of Antioxidant Vitamins (A, E, C) and Lipid Peroxidation Levels in Rats Injected N-(1,3-Benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine

by
F. Karatas
1,*,
H. Kara
2,
S. Servi
1,
T. Tug
3,
F. A. Erulas
1 and
M. Koca
1
1
Department of Chemistry, College of Science, Firat University, Elazig 23119, Turkey
2
Elazig School of Health Sciences, Firat University, Elazig 23119, Turkey
3
Faculty of Medicine, Department of Chest Diseases, Firat University, Elazig 23119, Turkey
*
Author to whom correspondence should be addressed.
Molecules 2005, 10(8), 922-928; https://doi.org/10.3390/10080922
Submission received: 4 September 2004 / Revised: 16 March 2005 / Accepted: 20 March 2005 / Published: 31 August 2005
Browse Figures
Versions Notes

Abstract

:
The present study examined the influence of synthetic N-(1,3-benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine (2-Amdz) on levels of vitamins A, E and C and malondialdehyde (MDA) in rats. A total of 30 rats, divided into two groups, were used in the study. The control group was given only a subcutaneous injection of 250 µL 75% ethanol, every other day. The other group of rats was administered a subcutaneous injection of 2-Amdz (25 mg kg-1, dissolved in 250 µL of 75% ethanol). Injections were continued for 16 days. After the application of 2-Amdz for 16 days, the serum levels of vitamins A, E and C and malondialdehyde (MDA) were determined by HPLC. The serum vitamin A, E, and C levels decreased significantly compared to controls (p<0.05) whereas serum MDA levels were higher than control levels (p<0.005). As a result, it can be suggested that 2-Amdz induced a severe stress and more importantly, increased the amount of free radicals and significantly decreased the levels of serum antioxidant vitamins.

Introductıon

Imidazolines and its aminoimidazolines derivatives have been widely used as medicines against a broad range of diseases because of their biological activities. These compounds are known to mediate a variety of biological actions on adrenergic [1, 2] and/or imidazoline [3] receptors. They also show various other effects such as lowering blood pressure [4, 5], sedation and anxiety reduction [6, 7], analgesic [5, 8], against alcohol withdrawal symptoms, as diuretic and antidiarreheal agents [5], anti-inflammatory [9], antimicrobial [10], cytotoxic [11], antiallergic [12], anesthetic [13] hypothermia, decreased salivary secretion and mydriasis activitities.
There are the studies examining the effects of benzimidazole and indazoles on oxidant-antioxidant systems, but not for imidazole and aminoimidazoles, therefore there is a need for studies investigating the effects of aminoimidazole compounds on oxidant and endogenous antioxidant systems. Endogenous antioxidant systems, the vitamins such as vitamins A, E and C, have been shown to react with organic free radicals and to protect biomembranes from damage induced by these free radicals. Antioxidant vitamins A, E and C are some of the major non-enzymatic antioxidants in the body [14, 15]. The aim of the present study was to investigate the effect of 2-aminoimidazoline (2-Amdz) administration on the levels of antioxidant vitamins A, E and C and of MDA, an indicator of lipid peroxidation in rats.

Results and Discussion

In Table 1 and Figure 1, it is seen that the rats subcutaneously injected 2-Amdz had low levels of antioxidant vitamins A, E and C in blood serum when compared with the control group (p<0.05). On the other hand, MDA levels clearly increased compared to the control group (p<0.005).
Table
Table I. The levels of antioxidant vitamins (A, E and C) and MDA of rats which was injected with 2-Amdz and the control groups. The results are given means ± SD.
Table I. The levels of antioxidant vitamins (A, E and C) and MDA of rats which was injected with 2-Amdz and the control groups. The results are given means ± SD.
Controls (n:15)2-Aminoimidazoline (n:15)p value
Vitamin A (µg/mL)0.82 ± 0.140.62 ± 0.17< 0.05
Vitamin E (µg/mL)8.62 ± 1.306.55 ± 1.50< 0.05
Vitamin C (µg/mL)9.64 ± 2.037.33 ± 1.53< 0.05
MDA (nmol/mL)1.84 ± 0.373.99 ± 0.77< 0.005
Lipid peroxidation is a free radical chain reaction [16] which causes the degeneration of cell membranes. Most products of lipid peroxidation are known to have mutagenic and/or carcinogenic properties [17]. Free radical species affect all important components of cells such as lipids, proteins, carbohydrates and nucleic acids [18]. Lipids are oxidized by free radical attack, and hence membranes are damaged [19]. Lipid peroxides are disintegrated quickly and form reactive carbon compounds. Among these, MDA is an important reactive carbon compound which is used commonly as an indicator of lipid peroxidation [20].
Molecules 10 00922 g001 550
Figure 1. Comparisons of the serum levels of vitamins A, E and C and MDA between rats injected with 2-Amdz and the control group.
Figure 1. Comparisons of the serum levels of vitamins A, E and C and MDA between rats injected with 2-Amdz and the control group.
Molecules 10 00922 g001
Although Can-Eke et al. showed that some benzimidazole compounds increased the lipid peroxidation of liver, lung and kidneys in rats under in vivo conditions [21], so far there have been no similar studies for amidoimidazoline compounds. Imidazoline compounds may protect beta cells against damage caused by IL-1beta-induced free oxygen and nitrogen radicals [22]. Nevertheless, in our study, it was observed that the injection of 2-Amdz to the rats significantly increased serum MDA levels compared to the control group (p<0.005) and it was found that 2-Amdz injected rats had decreased levels of antioxidant vitamins A, E and C in comparison to the control group (p<0.05). It has been reported that environmental chemicals and some drugs can decrease the antioxidant levels of the organism and thus could lead to cancer and various diseases. Therefore, drugs including antioxidant compounds are required from external sources [23].

Conclusions

It can be suggested that 2-Amdz produces more free radicals and in turn this decreases the level of antioxidant vitamins in the serum of rats. From these results, we could suggest that, antioxidant vitamins such as vitamin A, E, and C should be taken along with the medicine containing imidazoline groups to compensate the potential vitamin deficiency caused by these drugs.

Experimental

Animals

A total of 30 male Wistar rats (14-16 week old, 200-220 g) were used in this study. Upon arrival, the animals were allowed to acclimatize for two weeks. The rats were housed in a temperature controlled room (22-25°C) with a 12:12 light-dark cycle; water and food were given ad libitum. Animals were divided into two groups; one control group (n=15) and an experimental group (n=15). The experimental group was administered the compound 2-Amdz synthesized by Servi [24, 25] according to Scheme 1.
Molecules 10 00922 g002 550
Scheme 1.
Scheme 1.
Molecules 10 00922 g002
The control group was given only an injection of 250 µL of 75% ethanol the every other day. The other group of rats were injected with 2-Amdz (25 mg kg-1, dissolved in 250 µL of 75% ethanol). Injections were continued for 16 days. All animals were on a normal diet throughout the experimental period. Blood samples were harvested and kept at –20ºC until analyzed.

Determination of serum Vitamin A and E levels

Blood samples were centrifuged at 3000 rpm for 5 minutes at 4°C and the serum was separated. MDA and antioxidant vitamins (A, E and C) levels were determined in serum. The quantification was performed according to Miller et al. [26] utilizing HPLC. Separations were accomplished at room temperature with a Cecil liquid chromatography system (Series 1100) consisting of a sample injection valve (Cotati 7125) with a 20 μL sample loop, an ultraviolet (UV) spectrophotometric detector (Cecil 68174) operating at 326 and 296 nm for vitamin A and E respectively, an integrator (HP 3395) and a Techsphere ODS-2 packed (5 μm particle and 80 oA pore size) column (250x4.6 ID) with methanol- acetonitrile- chloroform (47: 42: 11, v/v) as the mobile phase at 1.0 mL min-1 flow rate.

Determination of serum Vitamin C and MDA levels

The extraction of vitamin C and free MDA were performed according to Cerhata et al. [27]. The supernatant was filtered and the vitamin C level was determined by using the method of Tavazzi et al. [28] and MDA levels by Karatas et al. [29]. A Supelcosil LC-18-DB HPLC reversed-phase column (3 μm particle size and 250 x 3.9 ID) was utilized for the detection of vitamin C and MDA levels. While a 3.7 mM phosphate buffer, pH 4.0 mobile phase was used at 1.0 mL min-1 flow rate to determine the vitamin C levels, the free MDA level was determined with a 30 mM KH2PO4 buffer, pH=4 with H3PO4 and methanol (65%-35% v/v) mobile phase at 1.5 mL min-1 flow rate. All chemicals and reagents used were of analytical grade and were purchased from Merck Chemical Co. (Darmstadt, Germany). Bidestilled water used to in the all studies.

Stastical Analysis

The SPSS software (SPSS Inc, Chicago, IL, USA) was used for statistical analyses. Results for the groups are expressed as means±S.D. Differences between the group’s means were analyzed for significance using the Mann-Whitney U-test. Statistical significance was defined as p<0.05.

References

  1. Hieble, J.P.; Bondinell, W.E.; Ruffolo, R.R. α- and β-adrenoreceptors: from the gene to the clinic.1. Molecular biology and adrenereceptor subclassification. J. Med. Chem. 1995, 38, 3415–3444. [Google Scholar]
  2. Ruffolo, R. R.; Bondinell, W.E.; Hielbe, J.P. α- and β-adrenoreceptors: from the gene to the clinic.2. Structure–activity relationships and therepeutic applications. J. Med. Chem. 1995, 38, 3681–3716. [Google Scholar]
  3. Matsuo, M.; Taniguchi, K.; Katsura, Y.; Kamitani, T.; Ueda, I. New 2-aryliminoimidazolidines. I. Synthesis and antihypertensive properties of 2-(2-phenoxyphenylimino)imidazolidines and related compounds. Chem. Pharm. Bull. (Tokyo). 1985, 33, 4409–4421. [Google Scholar]
  4. Dardonville, C.; Rozas, I. Imidazoline binding sites and their ligands: An overview of the different chemical structures. Med. Res. Rev. 2004, 24, 639–61. [Google Scholar]
  5. Mundla, S. R.; Wilson, L. J.; Klopfenstein, S. R.; Seibel, W. L.; Nikolaides, N. N. A novel method for the efficient synthesis of 2-arylamino-2-imidazolines. Tetrahedron Lett. 2000, 41, 6563–6566. [Google Scholar]
  6. Paterson, L M.; Tyacke, R. J.; Nutt, D. J.; Hudson, A. L. Relationship between imidazoline(2) sites and monoamine oxidase. Ann. N. Y. Acad. Sci. 2003, 1009, 353–356. [Google Scholar]
  7. Alemany, R.; Olmos, G.; Garcia-Sevilla, J. A. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn Schmiedebergs Arch. Pharmacol. 1997, 356, 39–47. [Google Scholar]
  8. Sanchez-Blazquez, P.; Boronat, M. A.; Olmos, G.; Garcia-Sevilla, J. A.; Garzon, J. Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br. J. Pharmacol. 2000, 130, 146–152. [Google Scholar]
  9. Holsapple, M. P.; Trizzino, J.; Nichols, D. E.; Yim, G. K. Therapeutic and adjunctive applications of an imidazoline anti inflammatory agent. J. Pharmacol. Exp. Ther. 1983, 224, 567–571. [Google Scholar]
  10. Kiec-Kononowicz, K.; Szymanska, E.; Motyl, M.; Holzer, W.; Bialecka, A.; Kasprowicz, A. Synthesis, spectral and antimicrobial properties of 5-chloroarylidene aromatic derivatives of imidazoline-4-one. Pharmazie 1998, 53, 680–684. [Google Scholar]
  11. Terasawa, K.; Sugita, Y.; Yokoe, I.; Fujisawa, S.; Sakagami, H. Cytotoxic activity of 5-benzoylimidazole and related compounds against human oral tumor cell lines. Anticancer Res. 2001, 21, 1081–1086. [Google Scholar]
  12. Olmos, G.; De Gregorio-Rocasolano, N.; Paz Regalado, M.; Gasull, T.; Assumpcio Boronat, M; Trullas, R.; Villarroel, A.; Lerma, J.; Garcia-Sevilla, J. A. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol. 1999, 127, 1317–1326. [Google Scholar]
  13. Graf, E.; Sieck, A.; Wenzl, H.; Winkelmann, J. Animal experiments on the safety pharmacology of lofexidine. Arzneimittel-Forsch. 1982, 32, 931–940. [Google Scholar]
  14. Laila, G.; Yues, A.; Bernard, H.; Claude, J.; Gerard, C.; Gerard, S. Biological variability of superoxide dismutase, glutathione peroxidase and catalase in blood. Clin. Chem. 1991, 37, 1932–1937. [Google Scholar]
  15. Halliwell, B. Free radical antioxidants in human disease. Curiosity, cause or consequence. Lancet 1994, 344, 721–724. [Google Scholar]
  16. Kappus, H.A. A survey of chemicals inducing lipid peroxidation in biological systems. Chem. Phys. Lipids 1987, 45, 105–115. [Google Scholar]
  17. Fang, J.L.; Vaca, C.E.; Valsta, L.M.; Mutanen, M. Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis 1996, 17, 1035–1040. [Google Scholar]
  18. Sarkar, S.; Yadav, P.; Bhatnagar, D.J. Cadmium-induced lipid peroxidation and the antioxidant system in rat erythrocytes: the role of antioxidants. Trace Elem. Med. Biol. 1997, 11, 8–13. [Google Scholar]
  19. Cheesman, K.H.; Slater, T.F. Introduction to free radical biochemistry. Br. Med. Bull. 1993, 49, 481–493. [Google Scholar]
  20. Jacob, R.A.; Burri, B.J. Oxidative damage and defense. Am. J. Clin. Nutr. 1996, 63, 985–990. [Google Scholar]
  21. Can-Eke, B.; Puskullu, M.O.; Buyukbingol, E.; Iscan, M. A study on the antioxidant capacities of some benzimidazoles in rat tissues. Chem. Biol. Interact. 1998, 113, 65–77. [Google Scholar]
  22. Papaccio, G.; Nicoletti, F.; Pisanti, FA; Galdieri, M.; Bendtzen, K. An imidazoline compound completely counteracts interleukin-1[beta] toxic effects to rat pancreatic islet [beta] cells. Mol Med. 2002, 8, 536–545. [Google Scholar]
  23. Sogawa, S.; Nihro, Y.; Ueda, H.; Miki, T.; Matsomota, H.; Satoh, T. Protective effects of hydroxychalcones on free radical-induced cell damage. Biol. Pharm. Bull. 1994, 17, 251–256. [Google Scholar]
  24. Servi, S. The efficient synthesis of 2-arylamino-2-imidazolines, 2-heteroaryl substituted benzimidazoles, and their morpholin-4-ylmethyl derivatives. S. Afr. J. Chem. 2002, 55, 119–123. [Google Scholar]
  25. Genc, M; Servi, S. Microwave-Assisted Rapid Synthesis of 2-Arylamino-2-Imidazolines on a Solid-Support. Heteroatom Chem. 2005, 16. in press. [Google Scholar]
  26. Miller, K.W.; Lorr, N.A.; Yang, C.S. Simultaneous determination of plasma retinol, α-tocopherol, lycopene, α-carotene, and β-carotene by high performance liquid- chromatography. Anal. Biochem. 1984, 138, 340–345. [Google Scholar]
  27. Cerhata, D.; Bauerova, A.; Ginter, B. Determination of ascorbic acid in serum using high performance liquid-chromatography and its correlation with spectrophometric (colorimetric) determination. Caska Slov. Farm. 1994, 43, 166–168. [Google Scholar]
  28. Tavazzi, B.; Lazzarino, G.; Di-Piero, D.; Giardina, B. Malondialdehyde production and ascorbate decrease are associated to the reperfusion of the isolated postischemic rat heart. Free Radic. Biol. Med. 1992, 13, 75–78. [Google Scholar]
  29. Karatas, F.; Karatepe, M.; Baysar, A. Determination of free malondialdehyde in human serum by high performance liquid chromatography. Anal. Biochem. 2002, 311, 76–79. [Google Scholar]
  • Sample Availability: Contact the authors.

Share and Cite

MDPI and ACS Style

Karatas, F.; Kara, H.; Servi, S.; Tug, T.; Erulas, F.A.; Koca, M. Investigation of Antioxidant Vitamins (A, E, C) and Lipid Peroxidation Levels in Rats Injected N-(1,3-Benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine. Molecules 2005, 10, 922-928. https://doi.org/10.3390/10080922

AMA Style

Karatas F, Kara H, Servi S, Tug T, Erulas FA, Koca M. Investigation of Antioxidant Vitamins (A, E, C) and Lipid Peroxidation Levels in Rats Injected N-(1,3-Benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine. Molecules. 2005; 10(8):922-928. https://doi.org/10.3390/10080922

Chicago/Turabian Style

Karatas, F., H. Kara, S. Servi, T. Tug, F. A. Erulas, and M. Koca. 2005. "Investigation of Antioxidant Vitamins (A, E, C) and Lipid Peroxidation Levels in Rats Injected N-(1,3-Benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine" Molecules 10, no. 8: 922-928. https://doi.org/10.3390/10080922

Article Metrics

Back to TopTop